Clinical Trial Update: Randomized Study to Reduce Calcineurininhibitor Toxicity in Pediatric and Adolescent Kidney Transplant Recipients [Phase 4]

View source ↗

Summary

This trial update notes termination of a Phase 4 randomized study aiming to reduce calcineurin-inhibitor toxicity in pediatric and adolescent kidney transplant …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Snippet

Sponsor: University of Erlangen-Nürnberg Medical School | Conditions: Kidney Transplant | Phase 4 | Status: TERMINATED